Tapering Prazosin When Switching to Clonidine

Key Pharmacologic Differences

Prazosin is an alpha-1 adrenergic receptor blocker that causes peripheral vasodilation without significant withdrawal phenomena, as noted by the American College of Cardiology 1, 2, 3
Clonidine is a central alpha-2 agonist that suppresses sympathetic outflow and requires careful tapering when discontinuing it to avoid rebound hypertension, according to the American College of Cardiology 1, 2, 3

The American College of Cardiology/American Heart Association guidelines explicitly warn that clonidine must be tapered to avoid rebound hypertension and potential hypertensive crisis when discontinuing this medication, with a strength of evidence supporting this recommendation 1, 2, 3, 4, 5

The American College of Cardiology recommends initiating clonidine at 0.1 mg twice daily while continuing prazosin, then titrating clonidine to effective dose over several days, and finally discontinuing prazosin abruptly without taper once blood pressure is controlled on clonidine 1, 2, 3
Monitoring for orthostatic hypotension during the transition is crucial, as both agents can cause this, particularly in older adults, as advised by the American College of Cardiology 1, 2, 3

The American College of Cardiology advises never to abruptly stop clonidine once the patient is established on it, as this requires careful tapering if ever discontinued 1, 2, 3
The American College of Cardiology recommends not stopping prazosin before starting clonidine, as this creates a gap in blood pressure control without the withdrawal risk that necessitates tapering 1, 2
Monitoring standing blood pressure during the switch is essential, as both medications cause orthostatic hypotension, especially in elderly patients, as noted by the American College of Cardiology 1, 2, 3